TNXP trade ideas
TNXP - Surely Not! 😬😬😬TNXP looks like it may be breaking down from a continuation pattern.
Price has never moved past the 20Mma and it is brushing against it here. Good chance collapse is coming and another leg down the mountain.
If it is a continuation then from the thrust candle top, a 1:0.618 extension takes price to $0.029!
And a 1:1 would see price get to a staggering $0.0018! 😬😬😬
I'd buy a few at that price!
TNXP to $4 by EOY?First post on TradingView.
I have been watching TNXP for about two months now, amazing pipeline, disappointing history, confusing CEO, and way undervalued.
This is my take on the upcoming several months; it could go up a lot sooner, but this is the general trend that you'll see as we move. $4/share by EOY is a conservative estimate, but do your own DD.
The largest falling wedge. I can't wait.Good morning everyone.
If you bought TNXP don't panic about what is happening now, if you see the chart this is a 10-year falling wedge that can break at any moment.
Now we are in free fall let's say and that's why is better not to sell bc reversal is coming.
The parabolic day is coming but we don't know when.
Now save some money and wait for $0.15 or even $0.03 which is the bottom of the wedge to load more. But don't sell bc you never know when this thing is going to pop.
There are many facts happening around this stock and the first is: This is the stock with the largest presence of institutional investors who own 5%, 4%, 3%, 2%, 1% of all the stocks and while the price keeps going down they are loading more and more starting from the largest investor BlackRock. So, are we understanding what is going on? They are buying from paper hand investors at Black Friday prices, so stay strong and load more and more if you can afford it.
These large investors are thinking in the long run, of the company they’re focused on pipeline and capacity to deliver it. The 3 new locations under build and refurbishments paid for by strategic partners/ investors all demonstrate their focus right now and confidence in TONIX products.
Why do I care if from $0.65 went to $0.27 or even goes lower when I can keep buying more and more understanding this can go to $40/share.
In my case I'm happy with the number of shares I own, I won't buy anymore I will just wait. If keeps going down I will buy if touches $0.15 and if touches $0.03.
In the meantime, I will go to the park with my kids living life to the fullest.
This stock is popping big time so let it bake for the big party.
If this analysis was for you please add a comment, like and follow me, I will post another analysis in a few days.
NASDAQ:TNXP
TNXP: buying at these levelsTNXP fib levels as shown. Accumulating shares at this level and may see a possible last draw down to $0.18 if TNXP cannot hold the 1.618 fib retracement support level. If it holds, expect to fill the gap at $0.96 sometime this year. Penny shares are fun, but be cautious. I think any draw down from here should be a signal to keep buying. Best of luck and thanks to @bitfink for putting this on my radar.
Not financial advice
TNXPTonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) This penny stock deserves your attention going forward. The stock is forming an inverted head and shoulders pattern. If the stock can break Friday’s high of 44c, we should see a strong follow through move. TNXP will move very quickly, so keep a very close eye on the stock.
Reached the all time low. Hi everyone, Yurii Domaranskyi here. Let's take a look at the chart:
1. Price levels are working well.
2. Globally range, locally downtrend
3. there was no confirmation of the level before 2 days ago, you can see nicely on the m5 chart the players see the price level.
4. Distant test of the level
5. approached with bars a little bigger than usual, but no paranormal
6. approached slowly
7. there was accumulation before the level
8. there was a rollback
9. the instrument closed above the level
10. all-time low low level, from there, was made a huge move up
11. there is enough room for a move 1 to 5.1 r/r
12. no model descending lows, we can see the engulfing bar on daily
13. no news for the last 10 days
14. the price came from the above
15. the price has a big potential for reversal
16. no planned report in the next 2 weeks
Potential risk/reward ratio = 1 to 5.1 meaning that potential risk 100$ with the possibility to make 510$
If you find the work valuable, please, press a thumb up! 👍
TNXP - Could See $0.029!?TNXP breaking down from what appears to be a bear flag.
It tested but failed to find any support above the 20Mma.
Playing out as I said it would in my previous thread.
Next fibonacci step down is the 0.618 at $0.029.
Seems quite extreme but I just do the weather and thats the forecast.
Not advice.
TNXP Trend ReversalAfter months of nothing but sadness...TNXP showed up with some hope.
Positive Phase 1 Trial for their Depression Drug
The best Earnings Surprise (30%) that they have had to date. How did they pull that off?
There is something positive that generated that unaccounted for % increase...THAT WE DO NOT KNOW ABOUT YET!
The estimates on this stock were getting narrower and narrower. WS seemed to have a pretty good handle on what they would be bringing in.
But there is an UNACCOUNTED FOR ....20%
This stock is also one of those Russell-Runners...it will be hot till Mid-Feb. Last year it went up to 2.12 from about the same place we are now.
Do you know what date that increase started? Nov 9...the day they released their first positive earnings report in 4 months (sound familiar?)
Set you a stop-loss @ .55 and run with me!
TNXPShares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) are starting to heat up again and are worth watching in the coming future. Phase 3 results of Tonmya (TNX-102 SL) to be presented at ACR November 6, 2021 If volume can pick up, I think this stock can break through resistance at 60c and re-test its recent highs around 80c (gap zone).
TNXP 1-Month AnalysisThis is a NEWS stock. It lives and dies off of NEWS. Technical analysis ONLY will yield frustration. This stock must be invested in based on more than chart analysis. My personal reason for backing this one is two-fold. 1) They have NO debt. 2) They have a diverse PIPELINE that includes a COVID vaccine (1 and done...no every 4-month headache, no boosters...can you imagine?)
* - Initial drop due to negative (yet very subjective) early clinical trial results. Conducted simple clinical trial with placebo vs TNX-102 and based findings off of patients' self-evaluation of pain. Relying on the patients' pain scale is highly subjective. On top of that, they elected to see results too quick. Both of those factors combined can easily make for inaccuracies. This was not a strong enough news break to merit the kind of sell-off that took place. Previous clinical results were far more substantive and thorough. How quickly we forget.
** - Notice the change in volume since the drop. Yes, more shares are changing places because the price is lower and buying on the dip is popular, but this kind of sustainable increase in volume suggests institutional involvement. While the price is sitting down here (where it shouldn't be), Wall Street is loading up.
*** - The lowest TNXP went this year is .50. If this threshold breaks down, it will probably take a lot longer to get back to where it was.
**** - The highest TNXP reached this year was 2.11. From the bottom to the top is about a 300% difference. Analyst average PT is set at $3.25. From where we are now, that's a 500% increase. It is also a popular ROBINHOOD stock which means it has a backdoor possibility at a MOONSHOT. This clinical trial isn't over, they are not packing up and starting over.
Not a financial advisor The reason I am long on TNXP. On the day chart its clearly had its time in the gutter long enough to know how to climb out of it. With everything TNXP has going on and the support of the US government I believe TNXP time has come. I predict up at least to $3 by EOY. I've been buying as much as I can while under $1. Have a nice day!
“Our clinical, manufacturing, and regulatory teams are advancing four programs into clinical trials by the end of 2021,” said Seth Lederman, M.D., President and Chief Executive Officer. “We look forward to initiating Phase 2 studies of TNX-1300 for cocaine intoxication and TNX-1900 for chronic migraine in the third and fourth quarters of 2021, respectively. We also expect to initiate a Phase 3 study of TNX-102 SL for PTSD outside of the U.S. and a first-in-human study of TNX-2100, a skin test diagnostic for COVID-19 T cell immunity, in the fourth quarter of 2021.”
Dr. Lederman continued, “We are expanding our R&D and manufacturing facilities. In July we announced an agreement to acquire an infectious disease research facility in Frederick, MD, and earlier this month we began construction on our Advanced Development Center (ADC) in New Bedford MA. We expect these facilities, coupled with our planned commercial scale manufacturing facility for vaccines in Hamilton, MT, will enable us to avoid future outsourcing bottlenecks and to work with greater efficiency in developing our programs for COVID-19, its variants, and other infectious diseases.”
Dr. Lederman added, “Recent reports of COVID-19 outbreaks in the U.S. and elsewhere, due primarily to the Delta variant, point to the urgent needs for more robust vaccines and more potent antiviral therapeutics. We believe the recent steps we have taken to strengthen our internal capabilities with company-controlled R&D and manufacturing facilities will accelerate our full pipeline of COVID-19 product candidates, which currently includes the TNX-1800 vaccine, TNX-3500 antiviral, TNX-2100 diagnostic, and TNX-102 SL for treating Long COVID.”
ir.tonixpharma.com